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Abstract
Background: Retrovirus infection depends on binding of the retroviral envelope (Env) protein to
specific cell-surface protein receptors. Interference, or superinfection resistance, is a frequent
consequence of retroviral infection, and occurs when newly-synthesized Env binds to receptor
proteins resulting in a block to entry by retroviruses that use the same receptors. Three groups of
viruses demonstrate a non-reciprocal pattern of interference (NRI), which requires the existence
of both a common receptor utilized by all viruses within the group, and a specific receptor that is
used by a subset of viruses. In the case of amphotropic and 10A1 murine leukemia viruses (MLV),
the common and specific receptors are the products of two related genes. In the case of avian
sarcoma and leukosis virus types B, D, and E, the two receptors are distinct protein products of a
single gene. NRI also occurs between xenotropic and polytropic MLV. The common receptor,
Xpr1, has been identified, but a specific receptor has yet to be described.
Results: Using chimeric receptor proteins and interference studies, we have identified a region of
Xpr1 that is uniquely utilized by xenotropic MLV and show that this receptor domain is required
for non-reciprocal interference.
Conclusion: We propose a novel pattern of receptor usage by xenotropic and polytropic MLV to
explain the NRI observed between these viruses. We propose that the specific and common
receptor determinants for xenotropic and polytropic viruses are simultaneously present in discreet
domains of a single Xpr1 protein.
Background
Retroviral infection of a host cell is initiated by interaction
of the retroviral Env protein surface (SU) subunit with a
specific host cell receptor. This interaction triggers confor-
mational changes within the Env protein that bring the
virus and host cell membranes in close proximity, result-
ing in fusion and delivery of the viral capsids into the host
cell cytoplasm (reviewed in [1,2]). In addition to promot-
ing virus entry, the intracellular interaction of a viral Env
and its cognate receptor can limit subsequent infection by
subsequent viruses that bind the same receptor. This phe-
notype is referred to as interference or superinfection
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Analysis of human/hamster Xpr1 chimeras for receptor function Figure 1
Analysis of human/hamster Xpr1 chimeras for receptor function. The predicted transmembrane domain structure of 
Xpr1 is shown at top and a corresponding block diagram is shown just below with the extracellular loops (ECL) shown in grey. 
A series of chimeras were constructed by exchange of the indicated fragments of hXpr1 and haXpr1. Restriction enzyme sites 
used in construction of the Xpr1 chimeras are shown above the block diagram. Chimeric receptors were subcloned into a ret-
roviral expression vector and were transfected into CHO cells. The cells were then grown in medium containing G418 to 
select for expression of the Neo gene also carried by the expression plasmid. Cells were then exposed to LAPSN vectors 
bearing either the AKR6 or the 1E Env and the apparent titers of the vectors were determined. Results are means of at least 
two independent experiments with triplicate determinations in each experiment.
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resistance because it prevents reinfection of a cell by the
same virus strain, and has been used to classify viruses
that utilize common cell surface receptors. Currently,
mammalian retroviruses are divided into at least 10 differ-
ent interference groups [3,4]. Within these groups, several
retroviruses show a non-reciprocal interference pattern
(NRI), where infection by one virus will block infection by
a second virus, but infection by the second virus only
slightly inhibits infection by the first virus.
As the receptors for different retroviruses have been iden-
tified, it has become clear that NRI occurs in cases where
related viruses within an interference group utilize a par-
tially overlapping set of receptors for entry. In the case of
amphotropic and 10A1 MLV [5] these receptors are Pit1
(Slc20a1) and Pit2 (Slc20a2), the products of two differ-
ent genes with similar sequence and function. The phos-
phate transporter Pit2 serves as the receptor for both
amphotropic MLV [6,7] and 10A1 [8]. However, 10A1
also binds to the closely related phosphate transporter
Pit1, the receptor for gibbon ape leukemia virus (GALV)
[9] and feline leukemia virus subtype B (FeLV-B) [10].
Because the amphotropic Env cannot bind to Pit1, it can-
not block 10A1 infection of cells that express both recep-
tors, while the 10A1 Env can block amphotropic MLV
infection [8].
NRI also occurs among avian sarcoma and leukosis
viruses (ASLV) types B, D, and E. Viruses of types B and D
can interfere with each other as well as type E viruses,
whereas ASLV-E can interfere with itself, but not with
types B or D. This group of viruses have all been shown to
utilize a common receptor, CAR1 [11,12]. Immunopre-
cipitation studies with different viral Env proteins have
shown that this protein, encoded by the tv-b  locus in
chickens, produces two distinct protein products that dif-
fer in their disulfide bond pattern. One form, designated
the type 1 receptor, can interact with ASLV-B and ASLV-E,
whereas an additional form, the type 2 receptor, is specific
for ASLV-B [13].
Another set of retroviruses that show NRI are xenotropic
and polytropic MLV (X-MLV and P-MLV, respectively).
Studies in cells derived from mink and the wild mouse
Mus dunni demonstrated NRI between X-MLV and P-MLV
[4,14], implying the existence of a common receptor. In
both cases, initial infection of cells with X-MLV strains
resulted in complete resistance to subsequent infection by
P-MLV isolates. However, initial infection of cells with P-
MLV strains did not block infection by X-MLV, although
the X-MLV titers observed were decreased [4,14]. The
hypothesis that these viruses share a common receptor
was confirmed by the identification of a single cDNA from
humans [15,16] and mice [17] that could mediate infec-
tion of both viruses when expressed in resistant cells.
However, the identification of a single cell surface recep-
tor is inconsistent with the interference patterns observed
between these two viruses. Previously established mecha-
nisms of NRI would suggest the existence of a specific X-
MLV receptor that cannot be utilized by P-MLV. Screening
of cDNA libraries by three groups independently failed to
identify additional genes encoding a xenotropic specific
receptor. Furthermore, genetic studies in mice have
mapped susceptibility loci for xenotropic and polytropic
viruses to the same region of mouse chromosome 1, and
it is currently believed that these studies have identified
alleles of the same gene [18,19]. These studies collectively
argue against the existence of a separate locus encoding an
X-MLV specific receptor, and suggest that the specific and
the common receptor are encoded by the same gene.
The common receptor, designated Xpr1, is a multiple-pass
transmembrane protein of unknown function, although
the gene displays a high homology to the Saccharomyces
cerevisiae Syg1 gene. In yeast, Syg1 is involved in regula-
tion of G-protein mediated signaling [20]. Current topol-
ogy models predict that the receptor contains four
extracellular loops (ECL), and intracellular amino and
carboxy termini (Figure 1). Studies subsequent to the
identification of the receptor have found residues within
the putative third and fourth ECL, at amino acid positions
500 and 582 of the NIH Swiss mouse Xpr1 protein
(mXpr1), that are critical for X-MLV receptor function
[21]. Due to the ability of P-MLV isolates to utilize mXpr1,
a similar set of residues required for P-MLV function were
not identified. Our initial studies have focused on exam-
ining the determinants for both X-MLV and P-MLV in the
same receptor. Making use of chimeras between the func-
tional human and the nonfunctional hamster Xpr1
orthologs, we have identified regions of human Xpr1 that
are sufficient to generate functional receptors for xeno-
tropic and polytropic viruses. These studies suggest that
two entry determinants are present on Xpr1. One determi-
nant in the putative fourth ECL can be utilized by X-MLV
and P-MLV, while a second determinant present in the
third ECL can only be used by X-MLV. These results and
additional interference studies support a novel model to
explain NRI between these two virus types and have iden-
tified the xenotropic-specific receptor determinant as a
particular domain of Xpr1.
Results
Role of the putative third and fourth ECL of Xpr1 in 
xenotropic and polytropic virus entry
To identify regions of human Xpr1 (hXpr1) that are
required for xenotropic and polytropic virus receptor
function, chimeric receptors combining coding sequences
from hXpr1 and from the non-functional hamster recep-
tor (haXpr1) were made and tested for receptor function
following expression in Chinese hamster ovary (CHO)Retrovirology 2005, 2:76 http://www.retrovirology.com/content/2/1/76
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Analysis of AKR6 and 1E virus interference in CHO cells expressing the AAUU and AAAU chimeric receptors Figure 2
Analysis of AKR6 and 1E virus interference in CHO cells expressing the AAUU and AAAU chimeric receptors. 
CHO cells transduced by retroviral vectors expressing the chimeric receptors AAUU or AAAU were infected with AKR6 or 
1E viruses by maintenance of the cells in virus-containing medium or in standard medium (mock infected) for six weeks. After 
infection the cells were seeded into 6-cm-diameter dishes, were exposed to vectors bearing the indicated Env, and vector tit-
ers were determined. Data from two independent infection/vector-titer-measurement experiments, one represented by grey 
boxes and the other by black boxes, are shown. Titer measurements in each experiment were performed in triplicate.
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cells (Figure 1). Chimeric receptors were named based on
the order of human (U) and hamster (A) sequences that
include the putative extracellular domains of the receptor.
Because CHO cells can be infected by some X-MLV strains,
we used the Env from an X-MLV strain (AKR6) that was
unable to mediate transduction of CHO cells even when
haXpr1 was overexpressed in the cells (Figure 1, construct
AAAA). We also tested the Env from a P-MLV strain (1E)
of Friend mink cell focus-forming virus (FrMCF) that
mediates only a low rate of transduction of CHO cells
overexpressing haXpr1 (Figure 1, construct AAAA). Both
Env proteins could mediate relatively efficient transduc-
tion of CHO cells expressing hXpr1 (Figure 1, construct
UUUU).
CHO cells expressing the Xpr1 chimeras were exposed to
xenotropic [LAPSN(AKR6)] or polytropic [LAPSN(1E)]
vectors and vector titers were determined (Figure 1). Cells
expressing the UUAA chimera were poorly transduced by
LAPSN(AKR6) or LAPSN(1E). Conversely, cells expressing
the AAUU chimera were transduced at levels only slightly
lower than those observed for hXpr1, indicating that the
third and fourth loops of hXpr1 are important for both
xenotropic and polytropic virus receptor function. Addi-
tional analysis of the determinants in this region shows
that either the third or the fourth ECL is sufficient for
xenotropic virus entry, but that only the fourth ECL can
mediate polytropic virus entry. In particular, the AKR6
xenotropic vector could efficiently transduce cells express-
ing the AAAU or the AAUA chimeras, while the 1E poly-
tropic vector could infect cells expressing the AAAU
chimera but not the AAUA chimera.
Xenotropic and polytropic Env show reciprocal 
interference on some chimeric receptors
In previous interference studies, infection with a xeno-
tropic virus blocks subsequent infection by viruses bear-
ing either xenotropic or polytropic Env. In contrast,
expression of a polytropic Env blocks subsequent infec-
tion by other polytropic viruses, but only slightly inhibits
xenotropic infection [4,14]. Using our chimeric Xpr1 pro-
teins, we examined the requirement for different regions
of Xpr1 in interference between AKR6 and 1E pseudotype
vectors.
To establish CHO cell lines expressing both a chimeric
Xpr1 receptor and a retroviral Env, CHO cells were trans-
duced with retroviral vectors expressing the chimeric
receptors and were then maintained in medium contain-
ing replication-competent AKR6 or 1E virus for a period of
6 weeks, as described in Materials and Methods. Cells
expressing Xpr1 chimeras and viral Env proteins were
challenged with LAPSN(AKR6) or LAPSN(1E) vectors. The
level of interference was determined by comparing the tit-
ers of LAPSN(AKR6) and LASPN(1E) vectors on mock
infected cells versus that on cells infected with a replica-
tion competent virus. In CHO cells expressing the AAUU
chimera we observed a non-reciprocal pattern of interfer-
ence between AKR6 and 1E viruses (Figure 2, left panels)
similar to that reported previously. Specifically, CHO/
AAUU cells infected with AKR6 virus were refractory to
transduction by both LAPSN(AKR6) and LAPSN(1E),
while CHO/AAUU cells infected with 1E virus were fully
susceptible to transduction by LAPSN(AKR6) and were
somewhat resistant to transduction by LAPSN(1E). The
weak resistance of the 1E-infected CHO/LAAUUSN cells
to transduction by LAPSN(1E) is somewhat surprising
given that significant levels of interference have previously
been described with this Env [4]. The titer we observed
was only 10 fold lower than that observed in mock
infected CHO/LAAUUSN cells, but was reproduced in
multiple independent experiments. Taken together, these
results demonstrate NRI for xenotropic and polytropic
viruses in CHO cells expressing the AAUU chimeric recep-
tor, similar to that observed previously for xenotropic and
polytropic viruses.
The interference patterns on CHO/AAAU cells were mark-
edly different from those described for CHO/AAUU cells.
The AAAU receptor contains only a single entry determi-
nant that can be utilized by both AKR6 and 1E pseudo-
typed viruses. In cells expressing this receptor,
transduction by the LAPSN(AKR6) or LAPSN(1E) vectors
was blocked by the presence of either AKR6 or 1E Env
(Figure 2, right panels), thus showing a pattern of recipro-
cal interference. Although transduction by LAPSN(AKR6)
was not completely blocked by 1E Env, a similar degree of
interference was observed in two independent experi-
ments, and the observed differences in titer were found to
be statistically significant in both cases by using the Stu-
dent's t-test (p < 0.05).
In summary, these experiments demonstrate a non-recip-
rocal interference pattern between AKR6 and polytropic
viruses on the AAUU chimera, and a reciprocal pattern of
interference in the AAAU chimera, which contains only
the putative fourth ECL of human Xpr1. These results sup-
port the hypothesis that xenotropic virus can utilize either
the third or fourth ECL of hXpr1 for cell entry, but that
polytropic virus can only use the fourth ECL. When the
third ECL is replaced with the non-functional loop from
haXpr1, both viruses can only use the fourth ECL for entry
and therefore show reciprocal interference.
SU domains of AKR6 and 1E Env show high sequence 
similarity to prototypical xenotropic and polytropic Env 
SU domains
To characterize the interaction of AKR6 and 1E Env pro-
teins with Xpr1 in more detail, we isolated and cloned the
receptor-binding surface (SU) subunits from both pro-Retrovirology 2005, 2:76 http://www.retrovirology.com/content/2/1/76
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teins. The sequence of the SU region of each Env protein
was determined by sequencing a PCR fragment isolated
from Hirt DNA extracted from virus-infected dunni cells.
Amino acid sequence alignments of AKR6 and 1E SU
regions and the those of the prototypic NZB X-MLV
[22,23] and FrMCF P-MLV [24] strains shows that the 1E
sequence is most like that of the FrMCF virus and the
AKR6 sequence is most like that of the NZB sequence (Fig-
ure 3). For example, the 1E Env sequence contains a four
residue deletion relative to NZB and AKR6 xenotropic Env
proteins that is also present in the FrMCF polytropic Env.
Additional sequence differences between the Env pro-
teins, many of which occur in two variable regions, are
likely to account for differences in host range observed
between these viruses.
A full-length env gene containing the cloned AKR6 SU
sequence and the transmembrane (TM) subunit sequence
from NZB X-MLV was constructed and was transfected
into LGPS/LAPSN cells to generate LAPSN(AKR6env)
virus. The titer of this virus on dunni cells was 3 × 104 AP+
FFU/ml. To verify the identity of the cloned AKR6 Env, we
measured the titer of the LAPSN(AKR6env) vector on
dunni cells previously infected with replication compe-
tent AKR6 or 1E viruses (Figure 4A). LAPSN(AKR6env)
transduction of dunni/AKR6 cells was almost completely
Amino acid sequence comparison of the Env SU domains of AKR6 X-MLV, 1E P-MLV, and prototypic X-MLV and P-MLV Figure 3
Amino acid sequence comparison of the Env SU domains of AKR6 X-MLV, 1E P-MLV, and prototypic X-MLV 
and P-MLV. Amino acid alignment of the Env SU domains of NZB X-MLV [GenBank:K02730], AKR6 X-MLV [Gen-
Bank:DQ199948], 1E P-MLV [GenBank:DQ199949], and FrMCF P-MLV [GenBank:X01679]. Sequences are shown starting 
with the initiator methionine and include endoplasmic reticulum signal sequences of unknown lengths. Variable regions A and 
B, believed to be responsible for receptor recognition [45], are indicated by brackets. Non-conservative amino acids differ-
ences are indicated by black boxes and conservative changes are indicated by grey boxes. Blue boxes indicate amino acids that 
are identical among the P-MLVs but dissimilar from one or more of those of the X-MLVs, identical among the X-MLVs but dis-
similar from one or more of those of the P-MLVs, or both. Cyan boxes indicate amino acids that are identical among the P-
MLVs and similar to those of the X-MLVs, identical among the X-MLVs and similar to those of the P-MLVs, or both.
       . . . .10 . . . .20 . . . .30 . . . .40 . . . .50 . . . .60 . . . .70 . . . .80 
NZB   MEGSAFSKPLKDKINPWGPLIVMGILVRAGASVQRDSPHQIFNVTWRVTNLMTGQTANATSLLGTMTDTFPKLYFDLCDL  80 
AKR6  MEGSAFSKPLKDKINPWGPLIVIGILVRAGASVQRDSPHQVFNVTWRVTNLMTGQTANATSLLGTMTDTFPKLYFDLCDL  80 
1E    MEGSAFSKPLKDKINPWGPLIVLGILIRAGVSVPHDSPHQVFDVTWRVTNLMTGQTANATSLLGTMTDAFPKLYFDLCDL  80 
FrMCF MEGPAFSKPLKDKINPWGPLIVLGILIRAGVSVQHDSPHQVFNVTWRVTNLMTGQTANATSLLGTMTDAFPMLYFDLCDL  80 
 
       . . . .90 . . . 100 . . . 110 . . . 120 . . . 130 . . . 140 . . . 150 . . . 160 
NZB   VGDYWDDPEPDIGDGCRTPGGRRRTRLYDFYVCPGHTVPIGCGGPGEGYCGKWGCETTGQAYWKPSSSWDLISLKRGNTP 160 
AKR6  VGDHWDDPEPDIGDGCRSPGGRKRTRLYDFYVCPGHTVPTGCGGPREGYCGKWGCETTGQAYWKPSSSWDLISLKRGNTP 160 
1E    IGDDWD----ETGLGCRTPGGRKRARTFDFYVCPGHTVPTGCGGPREGYCGKWGCETTGQAYWKPSSSWDLISLKRGNTP 156 
FrMCF IGDDWD----ETGLGCRTPGGRKRARTFDFYVCPGHTVPTGCGGPREGYCGKWGCETTGQAYWKPSSSWDLISLKRGNTP 156 
 
       . . . 170 . . . 180 . . . 190 . . . 200 . . . 210 . . . 220 . . . 230 . . . 240 
NZB   KDQGPCYDSSV-SSGVQGATPGGRCNPLVLEFTDAGRKASWDAPKVWGLRLYRSTGADPVTRFSLTRQVLNVGPRVPIGP 239 
AKR6  RGQGPCYDSSVVSSSVQGATPGGRCNPLVLEFTDAGRKASWDAPKAWGLRLYRSTGTDPVTLFSLTRQVLNVGPRVPIGP 240 
1E    RNQGPCYDSSVVSSGIQGATPGGRCNPLVLEFTDAGKKASWDGPKVWGLRLYRSTGIDPVTRFSLTRQVLNIGPRIPIGP 136 
FrMCF RNQGPCYDSSVVSSGIQGATPGGRCNPLVLEFTDAGKKASWDGPKVWGLRLYRSTGIDPVTRFSLTRQVLNIGPRIPIGP 136 
 
       . . . 250 . . . 260 . . . 270 . . . 280 . . . 290 . . . 300 . . . 310 . . . 320 
NZB   NPVITDQLPPSQPVQIMLPRPPHPPPSGTVSMVPGAPPPSQQPGTGDRLLNLVEGAYQALNLTSPDKTQECWLCLVSGPP 319 
AKR6  NPVITDQLPPSRPVQIMLPRPPHPPPTGAASMVPGALPPSQQPGTGDRLLNLVEGAYQALNLTSPDKTQECWLCLVSGPP 320 
1E    NPVITGQLPPSRPVQIRLPRPPQPPPTGAASMVPGTAPPSQQPGTGDRLLNLVDGVYQALNLTSPDKTQECWLCLVSAPP 316 
FrMCF NPVITGQLPPSRPVQIRLPRPPQPPPTGAASMVPGTAPPSQQPGTGDRLLNLVDRAYQALNLTSPDKTQECWLCLVSGPP 316 
 
       . . . 330 . . . 340 . . . 350 . . . 360 . . . 370 . . . 380 . . . 390 . . . 400 
NZB   YYEGVAVLGTYSNHTSAPANCSVASQHKLTLSEVTGQGLCVGAVPKTHQALCNTTQKTSDGSYYLAAPAGTIWACNTGLT 399 
AKR6  YYEGVAVLGTYSNHTSAPANCSVTSQHKLTLSEVTGQGLCVGAVPKTHQALCNTTQKTSDGSYYLASPAGTIWACSTGLT 400 
1E    YYEGVAVLGTYSNHTSAPANCSAASQHKLTLSEVTGRGLCIGTVPKTHQALCNTTLKTGKGSYYLVAPAGTMWACNTGLT 396 
FrMCF YYEGVAVLGTYSNHTSAPANCSVASQHKLTLSEVTGRGLCIGTVPKTHQALCNTTLKAGKGSYYLVAPTGTMWACNTGLT 396 
 
       . . . 410 . . . 420 . . . 430 . . . 440 . . . 450 . . . 460 . 
NZB   PCLSTTVLNLTTDYCVLVELWPKVTYHSPDYVYGQFEKKTKYKREPVSLTLALLLGGLTMGG 461 
AKR6  PCLSTTVLNLTTDYCVLVELWPKVTYHSPDYVYGQFEKKTKYKREPVSLTLALLLGGLTMGG 462 
1E    PCLSATVLNRTTDYCVLVELWPRVTYHPPSYVYSQFEKSYRHKREPVSLTLALLLGGLTMGG 458 
FrMCF PCLSATVLNRTTDYCVLVELWPRVTYHPSSYVYSQFEKSYRHKREPVSLTLALLLGGLTMGG 458 
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blocked (<10 AP+ FFU/ml). In contrast, the titer of this
vector on dunni/1E cells was reduced by only about 10-
fold. As a control, the titer of LAPSN(10A1) vector on
dunni and dunni/AKR6 cells was also measured. The
10A1 Env utilizes Pit1 and/or Pit2 for entry, and so should
not be affected by the presence of AKR6 xenotropic Env in
the cells. As expected, the LAPSN(10A1) titers were equiv-
alent on these cell lines (Figure 4A). The block to
LAPSN(AKR6env) transduction in cells chronically
infected with AKR6 suggests that the cloned sequence
encodes a protein that binds the same receptor as biolog-
ical isolates of AKR6. Furthermore, the infection patterns
observed on dunni/AKR6 and dunni/1E cells are consist-
ent with the NRI previously observed for X-MLV and P-
MLV.
A full-length env gene containing the cloned 1E SU
sequence and the transmembrane (TM) subunit sequence
from NZB X-MLV was constructed and was transfected
into LGPS/LAPSN cells, but vector production from these
cells was not detected. Examination of multiple 1E-SU
PCR clones isolated from various Hirt preparations of 1E
virus DNA indicated that the 1E-SU clone we used to con-
struct the Env expression vector does not contain inacti-
vating mutations. Attempts to clone the remaining TM
sequence from 1E Env by PCR using primers to conserved
regions of Env were unsuccessful, suggesting that 1E may
have unique sequences present in the TM domain that are
required for proper Env function.
To verify that the cloned 1E SU sequence had the proper-
ties of a polytropic virus SU domain, we generated a
human IgG tagged version of 1E-SU (1E-SU-IgG). Follow-
ing production of the protein by transient transfection
and purification by FPLC, we examined the binding of 1E-
SU-IgG to dunni cells by flow cytometry (Figure 4B). To
address the binding specificity of this reagent, and by
extension of our cloned SU sequence, we also examined
the binding to dunni cells infected with replication com-
petent 1E or with 4070A amphotropic viruses. Similar
binding of 1E-SU-IgG was observed in both control and
dunni/4070A, whereas reduced binding was observed in
dunni/1E cells. As a control, we found that Ampho-SU-
IgG protein binding to dunni cells was inhibited in cells
infected by an amphotropic virus (Figure 4C). The ability
of replication competent 1E virus to inhibit binding of 1E-
SU-IgG to cells demonstrates that the cloned SU recog-
nizes a protein that is also bound by the 1E virus isolate.
From this result, we conclude that the cloned SU sequence
is representative of the Env present in the 1E virus.
Analysis of xenotropic and polytropic Env binding to cells 
expressing human, hamster and chimeric receptors
The ability of AKR6-pseudotype vector to utilize chimeric
receptors that contain either of two non-overlapping
regions of hXpr1 suggests that this virus can bind inde-
pendently to either of the two regions of the cellular recep-
tor. To test this prediction, we measured binding of AKR6
virus to CHO cells expressing various receptors by FACS
analysis (Figure 5) using a rat antibody (83A25) that rec-
ognizes epitopes in the C-terminus of Env but does not
interfere with virus binding to cells [25]. We found a clear
increase in AKR6 virus binding to cells expressing hXpr1
in comparison to cells expressing haXpr1. AKR6 virus
binding to cells expressing the AAAU chimeric receptor
Binding and interference properties of cloned AKR6 SU and  1E SU Figure 4
Binding and interference properties of cloned AKR6 
SU and 1E SU. (A) LAPSN(AKR6env) and 
LAPSN(10A1env) vector titers were measured on dunni cells 
and dunni cells infected with replication-competent AKR6 or 
1E viruses. Data shown are means ± SD of at least two inde-
pendent experiments with duplicate determinations in each 
experiment. (B) Binding of 1E-SU-IgG to dunni cells and to 
dunni cells infected with replication-competent viruses. (C) 
Binding of Ampho-SU-IgG to dunni cells infected with 4070A 
amphotropic virus. Data in (B) and (C) are from a represent-
ative experiment and show data from ~18,000 live cells (cells 
that exclude propidium iodide) per histogram.
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was similar to that of cells expressing hXpr1, consistent
with the ability of the AAAU chimera to mediate entry of
vectors bearing the AKR6 Env. Interestingly, AKR6 virus
binding to cells expressing the AAUA chimera was much
higher than that of cells expressing hXpr1. It is important
to note that we have not determined the relative cell sur-
face expression levels of the receptors and receptor chi-
mera, and it is possible that differences in binding reflect
varied protein levels as opposed to differences in binding
affinities. However, binding of the AKR6 virus to cells
expressing the AAUA and AAAU chimeras at levels at least
as high as to cells expressing hXpr1 is consistent with the
hypothesis that the AKR6 Env can independently bind the
third or the fourth ECL of hXpr1.
The 1E-pseudotype vector could only utilize chimeric
receptors that contained the fourth ECL of hXpr1, suggest-
ing that only chimeric receptors containing the fourth ECL
of hXpr1 would bind the 1E Env. In this case we could not
measure 1E virus binding to cells because the 83A25 rat
antibody did not bind to the 1E Env (data not shown), in
agreement with previous data showing that 83A25 does
not recognize Env from some strains of FrMCF [25].
Instead, to measure 1E Env binding we measured binding
of the 1E-SU-IgG protein to cells expressing the chimeric
receptors (Figure 6). 1E-SU-IgG binding to hXpr1 was
higher than that to haXpr1, consistent with the difference
in receptor activities of these proteins. 1E-SU-IgG binding
to cells expressing the AAUA chimeric receptor was similar
to that for cells expressing hXpr1 while binding to cells
expressing the AAAU chimera was higher than that to
AAUA- or hXpr1-expressing cells. These results indicate
that the 1E Env can bind most efficiently to a receptor con-
taining the fourth ECL (AAAU), but equal binding of 1E
Env to AAUA and human Xpr1 was not expected based on
the 1E vector transduction data. As with the AKR6 virus
binding studies above, it is possible that differences in
receptor expression may have influenced these results. In
addition, there is relatively high binding of 1E-SU-IgG to
haXpr1, a poor receptor for 1E-pseudotype vectors.
Discussion
Results obtained here with the hamster/human receptor
chimeras are consistent with previous studies demonstrat-
ing the importance of residues within the putative third
and fourth ECL of Mus dunni Xpr1 in xenotropic receptor
function [21]. In that study, mutations in both the third
and fourth ECL of Mus dunni Xpr1 were required to abol-
ish xenotropic receptor function while mutations in either
ECL alone did not limit virus entry. In the current study,
the ability of AKR6 pseudotyped vectors to utilize either
the AAUA or the AAAU chimera as a receptor demon-
strates that either the third or fourth human ECL is suffi-
cient to support X-MLV entry.
Taken together, our experiments with chimeric receptors
suggest a model for entry of X-MLV and P-MLV that is con-
sistent with the NRI observed previously, given that no X-
MLV specific receptor has been identified. We propose
that two receptor functions are present simultaneously in
different domains of Xpr1. One domain, which resides in
the fourth ECL functions as a recognition site for both
xenotropic and polytropic viruses, while the second recep-
tor domain in the third ECL can only interact efficiently
with xenotropic Env.
Measurement of AKR6 virus binding to cells expressing chi- meric receptors Figure 5
Measurement of AKR6 virus binding to cells express-
ing chimeric receptors. CHO cells transduced with retro-
viral vectors expressing hamster, human or chimeric Xpr1 
receptor proteins were incubated with or without 
LAPSN(AKR6) virus and virus binding was detected by flow 
cytometry using the 83A25 anti-Env primary and a fluores-
cent secondary antibody. Each histogram represents 14,000 
to 18,000 live cells (cells that exclude propidium iodide). The 
experiments were repeated twice with similar results.
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Our model for NRI predicts that the xenotropic and poly-
tropic viruses should show a reciprocal pattern of interfer-
ence in a receptor lacking the X-MLV specific receptor
domain. The interference experiments described here
using the AAAU and AAUU chimeras confirm this predic-
tion. The interference pattern on the AAUU chimera,
which contains both entry domains, is non-reciprocal due
to the presence of the third extracellular loop. If the xeno-
tropic specific determinant is removed, as in the AAAU
chimera, X-MLV entry is markedly inhibited in cells
expressing the 1E Env. This finding demonstrates that the
third ECL is required for NRI, and that a chimeric receptor
lacking this region serves as a common receptor for both
P-MLV and X-MLV.
In the interference experiments described here, 1E Env
was sometimes unable to completely block infection by a
1E-pseudotype challenge vector (Table 2). Previous work
suggests that such incomplete interference may reflect an
inherent inability of P-MLV to completely block their cel-
lular receptor. In vitro studies specifically examining the
mechanism of P-MLV pathogenesis have shown that
infection of cells by polytropic/MCF viruses results in
accumulation of unintegrated extrachromosomal viral
DNA, suggesting that P-MLV are capable of superinfecting
cells in culture [26]. This finding is consistent with studies
from other oncoretroviral systems showing that patho-
genic viral stains can often superinfect cells [27-29]. Given
that receptor mediated interference is the primary mecha-
nism by which viruses prevent superinfection, the demon-
strated ability of P-MLV to initiate multiple rounds of
infection suggests that some polytropic Env proteins are
inherently incapable of blocking certain receptors. How-
ever, it should be noted that strong interference by poly-
tropic Env proteins can be observed in some cases (Table
2) [4].
It is tempting to speculate that the regions we have identi-
fied through our chimera analyses represent the motifs
within Xpr1 that are responsible for binding to the viral
Env. The critical portions of the molecule are believed to
lie outside of the cell, and therefore represent candidates
for SU binding domains. However, it is difficult to accu-
rately predict the topology of transmembrane receptors, as
was shown in the case of Pit1 and Pit2. Initial predictions
of receptor topology were used to design a number of chi-
meras similar to those described here. Regions within
those chimeras were identified that enhanced infection by
GALV or amphotropic MLV respectively, and it was sug-
gested that these regions were responsible for virus bind-
ing [30-33]. However, recent experiments have provided a
new, experimentally verified topology for Pit2 [34], and
several of the previously identified critical regions were
found to lie on the inner surface of the cell membrane.
Therefore, before a specific role can be firmly assigned to
the third and fourth ECL of Xpr1, the topology of the pro-
tein must be established.
Conclusion
Results presented here indicate that the non-reciprocal
interference between polytropic and xenotropic retrovi-
ruses can be explained by a common receptor domain in
the putative fourth ECL of Xpr1 and a specific receptor
domain for xenotropic virus in the third ECL of the same
Xpr1 protein.
Methods
Virus and cell line nomenclature
Cell lines containing integrated retroviral vectors are indi-
cated by the name of the cell line, followed by a slash, fol-
lowed by the name of the integrated vector (e.g. dunni/
LAPSN, or CHO/LN). Retroviral vectors in the viral form
are described by the vector name followed, in parentheses,
by the name of the replication-competent virus or packag-
ing cell line used to produce the vector [e.g.
LAPSN(AKR6), LAPSN(PA317)]. Where packaging cell
lines have been used, the Gag and Pol proteins are from
Moloney murine leukemia virus.
Cell culture
Chinese hamster ovary (CHO) cells (CHO-K1, ATCC CCL
61) were grown in minimum essential medium-alpha (α-
Measurement of 1E-SU-IgG binding to cells expressing chi- meric receptors Figure 6
Measurement of 1E-SU-IgG binding to cells express-
ing chimeric receptors. CHO cells transduced with retro-
viral vectors expressing hamster (AAAA, green), human 
(UUUU, red) or chimeric (AAUA, orange; AAAU, blue) 
Xpr1 receptor proteins were incubated with (solid lines) or 
without (dashed lines) purified 1E-SU-IgG, with fluorescent 
anti-IgG secondary antibody, and were analyzed by flow 
cytometry. All analyses were performed in the same experi-
ment with the same FACS settings. Each histogram repre-
sents ~13,000 live cells (cells that exclude propidium iodide). 
The experiment was repeated once with similar results.
CHO/AAAU
CHO/AAUA
CHO/AAAA
CHO/UUUU
Secondary 
antibody    
only
11 0 1 0 0
Fluorescence
150
120
90
60
30
0
C
e
l
l
 
n
u
m
b
e
rRetrovirology 2005, 2:76 http://www.retrovirology.com/content/2/1/76
Page 10 of 12
(page number not for citation purposes)
MEM) (Gibco) supplemented with 10% fetal bovine
serum (FBS) (Hyclone). All other cell lines were grown in
Dulbecco's minimal essential medium (DMEM) (Gibco)
supplemented with 10% FBS. CHO cells expressing chi-
meric receptors were generated by calcium phosphate-
mediated transfection of receptor expression constructs.
One day post-transfection, cells were trypsinized and
seeded at 1:10 dilution into medium containing G418
(750 µg active compound per ml) and were maintained in
selection medium for 7 to 10 days. Surviving cells were
pooled and utilized in subsequent transduction assays.
Mus dunni tail fibroblasts (dunni cells), the generation of
dunni/LN, dunni/LAPSN, and helper virus-infected deriv-
atives have been described [4]. LGPS/LAPSN cells [35] are
a clone of NIH 3T3 cells that express Moloney MLV Gag
and Pol proteins and contain the retroviral vector LAPSN
[6]. Retrovirus packaging cell lines used included PA317
[36], PD223 [37] and FlyRD [38]. All cells were grown in
a 37°C incubator at 10% CO2 and 100% relative humid-
ity.
Chimeric receptor plasmids and retroviral vectors
Receptor chimeras are named to indicate the origin of the
sequence in each putative extracellular loop, based on the
receptor topology model provided in Figure 1. This model
has been suggested in previous studies [21], and was con-
firmed for this study by using a number of topology pre-
diction algorithms located on the ExPASy proteomics
server [39]. For the human/hamster Xpr1 receptor chime-
ras (Figure 1), "A" indicates sequence from the Cricetulus
griseus  hamster receptor [GenBank:AF198106], while a
"U" is used for the human sequence derived from a HeLa
cell cDNA library [GenBank:AF099082]. Chimeric Xpr1
proteins were constructed by exchanging restriction frag-
ments as indicated in Figure 1. The 2 kb DNA fragments
containing the hXpr1 or haXpr1 coding regions were
blunt ended with Klenow and was cloned into SmaI
digested pBluescript II (Stratagene, La Jolla CA). Follow-
ing the exchange of fragments required to generate chi-
meric receptors, all constructs were confirmed by
sequencing using primers internal to the receptor
sequence. Retroviral vectors expressing the chimeric
receptors were made by insertion of 2 kb XhoI-BamHI frag-
ments containing the receptor coding regions from pBlue-
script into the retroviral expression plasmid LXSN [40]
after digestion of pLXSN with HpaI and BamHI. Addi-
tional retroviral vectors used here included LAPSN [6],
which encodes AP and Neo, and LN [40], which encodes
Neo.
Viruses and infection assays
The AKR6 xenotropic and 1E polytropic virus isolates were
a kind gift from Bruce Chesebro [14]. LAPSN(AKR6) and
LAPSN(1E) retroviral vectors were generated by infecting
dunni/LAPSN cells with AKR6 or 1E helper virus, as
described previously [4]. LAPSN(AKR6env) and
LAPSN(1Eenv) vectors were generated by transfection of
pSX2-AKR6env and pSX2-1Eenv into LGPS/LAPSN cells
using standard calcium phosphate protocols. Briefly,
LGPS/LAPSN cells were plated into 6-cm-diameter culture
dishes at 5 × 105 cells per dish approximately16 h prior to
transfection. The following day, 9 µg of the Env expression
plasmid was transfected into the cells with 1 µg of pCMV-
βgal as a control for transfection efficiency. The following
day cells were rinsed with PBS, and incubated with 4 ml
culture medium per plate overnight. The conditioned
medium was collected, filtered through a 0.45 µm pore-
size filter, and was frozen at -80°C. Vector titers were
determined by limiting dilution assay on dunni cells.
Additional viral vectors, including LAPSN (PA317),
LAPSN (PD223), and LAPSN(FlyRD), were obtained by
collecting conditioned medium from established pro-
ducer lines.
Transduction assays in cell lines expressing chimeric
receptors were carried out as follows. Approximately 16 h
before infection, cell lines were plated at 7 × 104 cells/well
into 6-well (d = 3.4 cm) tissue culture dishes. Immediately
prior to infection, medium was changed to include 4 µg/
ml Polybrene. Virus was added at appropriate dilutions,
and the cells incubated for 48 h to allow expression of the
alkaline phosphatase protein from the integrated LAPSN
vector. Cells were then fixed in 3.7% formaldehyde in
phosphate-buffered saline for 8 min at room temperature.
Fixed cells were washed three times with phosphate-buff-
ered saline. Endogenous alkaline phosphatase was inacti-
vated by incubating the cells at 68°C for 1 h. Cells were
then stained for alkaline phosphatase activity by incubat-
ing the cells over night in AP staining buffer (100 mM Tris
pH 8.5, 100 mM NaCl, 50 mM MgCl2, 1mg/ml Nitro Blue
tetrazolium, 100 µg/ml X-Phos). Transduction events
were measured by counting AP+ foci.
Env cloning
Env SU sequences from the AKR6 [GenBank:DQ199948]
and 1E [GenBank:DQ199949] viruses were obtained by
PCR from low molecular weight DNA obtained from
infected cells. Specifically, dunni cells were plated at 105
cells in 6-cm-diameter tissue culture dishes. Following
overnight incubation, the cells were infected at high mul-
tiplicity of infection (~100) with helper virus-containing
stocks of LAPSN(AKR6) and LAPSN(1E) in the presence of
4  µg/ml Polybrene (Sigma). 16 h post-infection, low
molecular weight DNA was isolated using the method of
Hirt [41]. Env sequences corresponding to the SU portion
of Env were isolated by PCR using primers Xeno5'env (5'-
ATGGAAGGTTCAGCGTTCTCAAAACCCC-3') and
Xeno3'Env (5'-TGCCGCCCATAGTAAGTCCTCC-3'). Fol-
lowing gel purification using a Qiaquick gel purification
kit (Qiagen), fragments were cloned into pCR2.1 using aRetrovirology 2005, 2:76 http://www.retrovirology.com/content/2/1/76
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Topo-TA cloning strategy (Invitrogen, Carlsbad CA). Full
length Env coding regions were generated by ligation of a
SacI-XhoI fragments into pBS-TM, a pBluescript-based vec-
tor containing a C-terminal fragment from the NZB env
gene [GenBank:K02730]. The pBS-TM plasmid was made
by insertion of a SacI-NotI fragment from pCSI-ENZB [16]
into pBluescript II. Expression plasmids were generated by
subcloning of XhoI-NotI fragments into pCR3.1 (Invitro-
gen) to generate pCR3.1-AKR6env and pCR3.1-1Eenv. To
improve expression in murine and CHO cells, a BamHI-
HincII fragment containing the human cytomegalovirus
immediate early promoter was replaced with a BamHI-
NheI fragment containing the Moloney MLV LTR pro-
moter and enhancer from pSX2 [42], to generate pSX2-
AKRenv and pSX2-1Eenv. These plasmids were sequenced
to confirm the presence of complete Env open reading
frames.
The 1E-SU-IgG plasmid was generated by ligation of a
SacI-XhoI fragment from pCR2.1-1E-Env into pCI-NSU?9-
hFc [16]. To confirm the identity and integrity of the
resulting fusion protein, the construct was sequenced
using primers internal to the 1E-SU.
Virus and Env SU binding assays
Production and purification of 1E-SU-IgG for binding
assays was carried out as described for other similar pro-
teins [43,44]. For flow cytometry assays, 106 cells were
incubated with 1–2 µg of purified fusion protein in a final
volume of 100 µl for 2 h. Following washing, cells were
incubated with a fluorescent anti human-IgG secondary
antibody (DAKO F0315) for 1 h. Cell fluorescence was
determined by flow cytometry on a FACSCalibur (BD Bio-
sciences), and data was analyzed using CellQuest soft-
ware.
For virus binding assays, 106 cells expressing the indicated
receptor chimeras were incubated with LAPSN(AKR6)
virus at 4°C for two h. Cells were washed three times with
phosphate-buffered saline containing 2% FBS and were
incubated with 1 ml hybridoma supernatant containing
83A25 antibody for 2 h. Following two additional washes
and incubation with a FITC-conjugated anti-Rat-IgG sec-
ondary antibody, cell fluorescence was determined by
flow cytometry using a FACSCalibur.
Interference assays
To establish CHO cell lines expressing high levels of AKR6
and 1E Env, cells were maintained in conditioned
medium from dunni/LN cells (mock), or dunni/LN cells
productively infected with AKR6 or 1E helper viruses.
Conditioned medium (α-MEM with 10% FBS) was col-
lected, centrifuged at 1,000 × g for 10 min to remove cells
and debris, and frozen at -80°C for 24 h. Prior to addition
to CHO cells, a 1:1 mixture of dunni conditioned medium
and fresh α-MEM with 10% FBS was supplemented with
4 µg/ml Polybrene to facilitate infection. The conditioned
medium mix was added to cells every 24 h. As CHO cul-
tures reached confluence (approximately every 3 days)
cells were removed from the culture dish with trypsin/
EDTA and split 1:10 into new 6-cm-diameter dishes. After
6 weeks, cells were trypsinized, counted on a hemacytom-
eter and plated at 105 cells/well in 6 well dishes. Cells were
then transduced with LAPSN(AKR) or LAPSN(1E) viral
vectors. The titer of each vector was determined by limit-
ing dilution. The degree of interference can be determined
by comparing the vector titer on mock infected cells to
that obtained on cells infected with AKR6 or 1E viruses.
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